Close

Capita Web Assist CapitaWebAssist


Hello! I’m CapitaWebAssist, your AI Virtual Assistant.

Please ask me anything about Capita - our expertise and solutions, what it's like to work here, news or our latest thinking.

I’m sorry, I do not know the answer to your question. You may be able to find your answer at www.capita.co.uk.

Potentially abusive, vulgar, or irreverent language detected. Please accept our apologies if this is an incorrect detection. Try asking again using different words.

CapitaWebAssist can make mistakes. The more specific your questions, the more accurate the responses are likely to be. Any important information should be separately verified.
CapitaWebAssist is powered by Black Sun Global

Access to the microphone has been blocked by your web browser.

You can configure your web browser to allow access to the microphone.

Share

The current landscape for procurement teams within the NHS is one that is consistently driving for savings to support Trusts’ financial positions, as non-pay costs continue to rise at a dramatic rate.

The current landscape for procurement teams within the NHS is one that is consistently driving for savings to support Trusts’ financial positions, as non-pay costs continue to rise at a dramatic rate. 

Outside of their ‘business as usual’ annual savings delivery targets, Procurement teams are challenged with scoping alternative areas of spend to identify opportunities to influence and improve the bottom line. One area that has previously been relatively untouched by procurement teams is pharmacy, usually due to the way it is structured and the nature of which it is managed within the NHS, as well as at a local Trust level. 

Safeguarding NHS value

NHS England’s Medicines Value and Access directorate oversees the strategic direction for the national pharmacy procurement strategy, and commercial arrangements are established by the Medicines Procurement and Supply Chain (MPSC) team for medicines used across the NHS. 

This covers a large proportion of pharmacy spend and provides a centrally-agreed commercial purchasing model for drugs and medicines. However, there remain areas of spend that are deemed as addressable outside of the focus of MPSC and existing regional collaborations that are purchased via pharmacy departments in Trusts. This is the area of pharmacy spend that procurement teams tend to have little visibility of due to the way it is managed, but where they can influence and further enhance potential benefits at a local level if given the opportunity to work alongside their clinical colleagues. 

Delivering value 

A lack of system harmonisation and limited insights within Trusts can become a barrier to informed data analysis, but strong stakeholder engagement and collaborative approaches to reviewing spend between procurement teams and pharmacy buyers can provide useful insight into additional areas of exploration. 

From specialist items that are an extension of spend currently managed by Trust teams, such as woundcare and haemostats, to pharmacy-specific items that are used in dispensary and aseptic wards, procurement teams can offer the potential to bring their expertise and ensure optimum value is achieved moving forwards. 

Find out how we’re working closely with our NHS clients to provide significant insights into these areas of spend and deliver commercial benefit: 

Written by

Hayley Wells

Hayley Wells

Managing Consultant, Health

Hayley Wells

Managing Consultant, Health

Hayley brings over 15 years of experience in clinical procurement across both the private and public healthcare sectors. She has a proven track record in delivering effective category management across medical portfolios and implementing strategies that drive meaningful cost savings. Passionate about collaboration, Hayley works closely with stakeholders to enable positive change, support growth, and achieve the best possible outcomes.

More of our insights

customer experience 2

Get in touch to see how we can transform your people capabilities